Galectin-1-Induced Autophagy Facilitates Cisplatin Resistance of Hepatocellular Carcinoma
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Galectin-1-Induced Autophagy Facilitates Cisplatin Resistance of Hepatocellular Carcinoma
Authors
Keywords
Autophagic cell death, Hepatoma cells, Hepatocellular carcinoma, Apoptosis, Mitochondria, Cancer treatment, Cell staining, Cancer chemotherapy
Journal
PLoS One
Volume 11, Issue 2, Pages e0148408
Publisher
Public Library of Science (PLoS)
Online
2016-02-10
DOI
10.1371/journal.pone.0148408
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumor suppressor functions of BNIP3 and mitophagy
- (2015) Aparajita H Chourasia et al. Autophagy
- Integrated Stable Isotope Labeling by Amino Acids in Cell Culture (SILAC) and Isobaric Tags for Relative and Absolute Quantitation (iTRAQ) Quantitative Proteomic Analysis Identifies Galectin-1 as a Potential Biomarker for Predicting Sorafenib Resistance in Liver Cancer
- (2015) Chao-Chi Yeh et al. MOLECULAR & CELLULAR PROTEOMICS
- Inhibition of Beclin 1 Expression Enhances Cisplatin-Induced Apoptosis Through a Mitochondrial-Dependent Pathway in Human Ovarian Cancer SKOV3/DDP Cells
- (2014) Yang Sun et al. ONCOLOGY RESEARCH
- Galectin-1 overexpression promotes progression and chemoresistance to cisplatin in epithelial ovarian cancer
- (2014) P Zhang et al. Cell Death & Disease
- Autophagy contributes to the survival of CD133+ liver cancer stem cells in the hypoxic and nutrient-deprived tumor microenvironment
- (2013) Yu-jiao Song et al. CANCER LETTERS
- Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment
- (2013) X Sui et al. Cell Death & Disease
- Targeting autophagy potentiates chemotherapy-induced apoptosis and proliferation inhibition in hepatocarcinoma cells
- (2012) Xian-ling Guo et al. CANCER LETTERS
- TLR2-dependent selective autophagy regulates NF-κB lysosomal degradation in hepatoma-derived M2 macrophage differentiation
- (2012) C-P Chang et al. CELL DEATH AND DIFFERENTIATION
- Galectin-1 Promotes Lung Cancer Progression and Chemoresistance by Upregulating p38 MAPK, ERK, and Cyclooxygenase-2
- (2012) L.-Y. Chung et al. CLINICAL CANCER RESEARCH
- Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
- (2012) Hashem B. El-Serag GASTROENTEROLOGY
- Overexpression of galectin-1 is associated with poor prognosis in human hepatocellular carcinoma following resection
- (2012) Han Wu et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Galectin-1 in Melanoma Biology and Related Neo-Angiogenesis Processes
- (2012) Véronique Mathieu et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Galectin 8 targets damaged vesicles for autophagy to defend cells against bacterial invasion
- (2012) Teresa L. M. Thurston et al. NATURE
- Withaferin A Synergizes the Therapeutic Effect of Doxorubicin through ROS-Mediated Autophagy in Ovarian Cancer
- (2012) Miranda Y. Fong et al. PLoS One
- Mitochondria removal by autophagy
- (2011) Ke Wang et al. Autophagy
- Inhibition of autophagy enhances cisplatin cytotoxicity through endoplasmic reticulum stress in human cervical cancer cells
- (2011) Ye Xu et al. CANCER LETTERS
- Novel roles of galectin-1 in hepatocellular carcinoma cell adhesion, polarization, and in vivo tumor growth
- (2011) María V. Espelt et al. HEPATOLOGY
- Regulation of Mammalian Autophagy in Physiology and Pathophysiology
- (2010) Brinda Ravikumar et al. PHYSIOLOGICAL REVIEWS
- Dysregulation of apoptosis in hepatocellular carcinoma cells
- (2009) Isabel Fabregat WORLD JOURNAL OF GASTROENTEROLOGY
- Blocked Autophagy Sensitizes Resistant Carcinoma Cells to Radiation Therapy
- (2008) A. Apel et al. CANCER RESEARCH
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started